Dong Wan-Tao, Gong Yan-Long, Song Min, Huang Kai, Dong Ping, Song Zhi-Jing, Wang Kai, Hai Yun-Xiang
Department of Joint Surgery, the Second Affiliated Hospital of Gansu University of TCM, Lanzhou 730020, China.
Clinical College of TCM, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 Sep;50(5):679-683.
To test the effects of Guben Zenggu Decoction on bone metabolism and bone microstructure in ovariectomized rats for the purpose of preventing and treating postmenopausal osteoporosis.
Osteoporosis rat models were established by ovariectomy. The model rats were randomly divided into control, estradiol valerate treatment, and Guben Zenggu Decoction treatment groups with high, medium and low dosages. After 12 weeks of treatments, 10 rats from each group were randomly selected for cardiac blood sampling after abdominal anesthesia. The serum levels of estradiol (E2), osteocalcin (BGP), carboxyterminal of type Ⅰ procollagen (PICP), collagen type Ⅰ pyridine crosslinking peptide (ICTP) and acid tartaric acid phosphatase-5b (TRAP-5b) were determined by ELISA. Bone histomorphometric analysis was performed on the right femoral specimen of rats using micro-CT imaging.
The models rats had lower levels of E2, bone alkaline phosphatase (BALP) and relative bone volume fraction (BV/TV), trabecular thickness (Tb.Th), number of trabeculae (Tb.N) and connectivity density (Conn.D), and higher levels of BGP, ICTP, PICP, TRAP-5b and degree of trabecular separation (Tb.Sp), structural model index (SMI) than their normal counterparts ( < 0.05). Estradiol valerate and Guben Zenggu Decoction treatments increased the levels of E2, BALP, BV/TV, Tb.Th, Tb.N, and Conn.D significantly ( < 0.05). Higher doses of Guben Zenggu Decoction resulted in higher changes ( < 0.05).
Guben Zenggu Decoction can improve bone metabolism and bone micro-structure in ovariectomized rats, thus playing a preventive and therapeutic role in postmenopausal osteoporosis.
观察固本增骨汤对去势大鼠骨代谢及骨微观结构的影响,探讨其防治绝经后骨质疏松症的作用机制。
采用去势手术建立骨质疏松大鼠模型,将造模成功的大鼠随机分为空白对照组、戊酸雌二醇组、固本增骨汤高、中、低剂量组。给药12周后,每组随机抽取10只大鼠,腹腔麻醉后心脏采血,采用酶联免疫吸附法(ELISA)检测血清雌二醇(E2)、骨钙素(BGP)、Ⅰ型前胶原羧基端肽(PICP)、Ⅰ型胶原吡啶交联肽(ICTP)及抗酒石酸酸性磷酸酶5b(TRAP-5b)水平;取大鼠右侧股骨,采用显微CT成像技术进行骨组织形态计量学分析。
与正常组比较,模型组大鼠血清E2、骨碱性磷酸酶(BALP)水平及骨组织相对体积分数(BV/TV)、骨小梁厚度(Tb.Th)、骨小梁数量(Tb.N)、连接密度(Conn.D)降低,血清BGP, ICTP, PICP, TRAP-5b水平及骨小梁分离度(Tb.Sp)、结构模型指数(SMI)升高(P<0.05)。戊酸雌二醇组和固本增骨汤各剂量组大鼠血清E2、BALP水平及骨组织BV/TV、Tb.Th、Tb.N、Conn.D均显著升高(P<0.05),且固本增骨汤高剂量组升高更明显(P<0.05)。
固本增骨汤可改善去势大鼠骨代谢及骨微观结构,对绝经后骨质疏松症具有防治作用。